GlassScriptPhysician profile
Loic S Tchokouani
NPI 1730574690
$97,731.38
in general payments reported to CMS, 2019-2025
21 companies · $30K in 2025
The $30K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,597 · 2022: $9,661 · 2023: $14K · 2024: $42K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $55K · Consulting Fee: $9,885 · Travel and Lodging: $7,946 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,000 · Food and Beverage: $5,142 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $54,500.00 |
| Consulting Fee | $9,885.07 |
| Travel and Lodging | $7,945.60 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,000.00 |
| Food and Beverage | $5,142.31 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $61,467.38 | 2022-2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Intuitive Surgical, INC. | $20,233.70 | 2021-2025 | Da Vinci Sp, Da Vinci Surgical System, Davinci Xi |
| Ethicon US, LLC | $10,190.87 | 2024 | Echelon Flex |
| Davol INC. | $1,657.05 | 2021-2023 | Phasix Mesh |
| Medical Device Business Services, INC. | $1,528.68 | 2022-2024 | |
| W. L. Gore & Associates, INC. | $823.59 | 2022-2023 | Seamguard, Gore Synecor Biomaterial, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Medtronic, INC. | $594.74 | 2022-2025 | Signia |
| Novo Nordisk INC | $291.79 | 2023-2025 | Wegovy, Rivfloza |
| Tela Bio, INC. | $250.74 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Bolton Medical INC | $144.00 | 2022 | |
| Baxter Healthcare | $133.04 | 2022 | |
| Reshape Lifesciences INC. | $118.45 | 2023 | |
| Currax Pharmaceuticals LLC | $64.93 | 2023 | Contrave, Onzetra Xsail |
| Lilly USA, LLC | $54.88 | 2023-2024 | Zepbound |
| Heron Therapeutics, INC. | $51.13 | 2023-2024 | Zynrelef, Aponvie |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.33 | 2021-2023 | Xifaxan, Trulance |
| Corcept Therapeutics | $20.24 | 2025 | Korlym |
| Idorsia Pharmaceuticals US INC | $20.00 | 2023 | Quviviq |
| Almatica Pharma LLC | $18.00 | 2021 | |
| Merck Sharp & Dohme LLC | $15.98 | 2023 | Verquvo |
| Teleflex LLC | $11.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loic Tchokouani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.